- Home
- THTX vs CBAT Comparison
THTX vs CBAT Comparison
Compare THTX & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- CBAT
- Stock Information
- Founded
- THTX 1993
- CBAT 1999
- Country
- THTX Canada
- CBAT China
- Employees
- THTX N/A
- CBAT 1456
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- CBAT Industrial Machinery/Components
- Sector
- THTX Health Care
- CBAT Miscellaneous
- Exchange
- THTX Nasdaq
- CBAT Nasdaq
- Market Cap
- THTX 93.3M
- CBAT 83.0M
- IPO Year
- THTX N/A
- CBAT N/A
- Fundamental
- Price
- THTX $1.48
- CBAT $0.92
- Analyst Decision
- THTX Hold
- CBAT
- Analyst Count
- THTX 1
- CBAT 0
- Target Price
- THTX N/A
- CBAT N/A
- AVG Volume (30 Days)
- THTX 108.7K
- CBAT 343.9K
- Earning Date
- THTX 02-19-2025
- CBAT 03-14-2025
- Dividend Yield
- THTX N/A
- CBAT N/A
- EPS Growth
- THTX N/A
- CBAT N/A
- EPS
- THTX N/A
- CBAT 0.12
- Revenue
- THTX $84,316,000.00
- CBAT $207,423,403.00
- Revenue This Year
- THTX $5.78
- CBAT $0.46
- Revenue Next Year
- THTX $2.47
- CBAT $13.78
- P/E Ratio
- THTX N/A
- CBAT $7.62
- Revenue Growth
- THTX 5.75
- CBAT 2.32
- 52 Week Low
- THTX $1.08
- CBAT $0.77
- 52 Week High
- THTX $2.18
- CBAT $2.08
- Technical
- Relative Strength Index (RSI)
- THTX 36.81
- CBAT 50.16
- Support Level
- THTX $1.42
- CBAT $0.86
- Resistance Level
- THTX $1.76
- CBAT $1.11
- Average True Range (ATR)
- THTX 0.09
- CBAT 0.04
- MACD
- THTX -0.05
- CBAT 0.00
- Stochastic Oscillator
- THTX 17.63
- CBAT 74.90
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.